跨性别包容性生育力保存在英国:临床指南、TransFertility服务模式与国家路径
本文综述了性别肯定激素治疗对生殖的影响、TGD人群生育力保存的临床结局、神经多样性与性别多样性的交叉,以及公平生殖照护的结构、人际和个体障碍;并介绍了伦敦Guy's and St Thomas' NHS基金会开发的TransFertility服务模式,该模式在39个月内转诊增加19倍以上、咨询出席率100%、治疗启动率超90%、完成率96.7%,无严重不良事件。作者认为缺乏英国国家路径是公平性缺口,该证据和模式可为制定国家共识指南提供基础。
要点
- 现有ESHRE、ASRM、WPATH和内分泌学会指南过于笼统,难以转化为可实施的国家路径。
- TransFertility模式实现转诊增19倍以上、咨询出席率100%、治疗启动超90%、完成率96.7%。
- 以烦躁知情照护为核心的多学科路径可改善TGD人群生育力保存的可及性、参与度和完成率。
核心结论
- 缺乏英国国家跨性别包容性生育力保存路径是关键的公平性缺口。
- 基于烦躁知情照护的TransFertility模式可复制,能改善TGD个体的可及性、参与度和治疗完成率。
- 本综述证据与TransFertility结局可为制定国家共识指南提供坚实基础。
研究设计与样本
- 综述整合性别肯定激素治疗的生殖效应、TGD人群生育力保存临床结局、神经多样性与性别多样性交叉及公平照护障碍的证据。
- 介绍在伦敦Guy's and St Thomas' NHS基金会信托开发的TransFertility服务模式。
- TransFertility模式在39个月内评估了转诊增长、咨询出席率、治疗启动率和完成率及不良事件。
主要发现
- TransFertility模式在39个月内转诊增加19倍以上。
- 该模式咨询出席率达100%,治疗启动率超过90%,治疗完成率达96.7%。
- 该模式未发生严重不良事件。
关键数值与推荐
- ESHRE、ASRM、WPATH和内分泌学会的现有指南过于笼统,无法直接转化为实施就绪的国家路径。
- TransFertility模式在39个月内转诊增加19倍以上、咨询出席率100%、治疗启动率超90%、完成率96.7%、无严重不良事件。
临床怎么用
- 采用烦躁知情照护框架设计多学科生育力保存服务。
- 对行政、临床和心理社会组件进行结构性重新设计以改善TGD个体照护。
- 以TransFertility模式为范本推动国家层面跨性别包容性生育力保存路径的共识制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transgender and gender-diverse (TGD) individuals face significant barriers to fertility preservation, yet existing guidance from ESHRE, ASRM, WPATH, and the Endocrine Society remains too general for translation into implementation-ready national pathways. This review synthesizes evidence on the reproductive effects of gender-affirming hormone therapy, clinical outcomes of fertility preservation in TGD populations, the intersection of neurodiversity and gender diversity, and the structural, interpersonal, and intrapersonal barriers to equitable reproductive care-translating this evidence into a trans-inclusive clinical pathway. We present TransFertility, a dysphoria-informed service model developed at Guy's and St Thomas' NHS Foundation Trust, London. Over 39 months, the model achieved a greater than 19-fold increase in referrals, 100% consultation attendance, over 90% treatment initiation, and 96.7% treatment completion, with no serious adverse events. The absence of a UK national pathway for trans-inclusive fertility preservation represents a critical equity gap. We propose that the evidence synthesized here, together with TransFertility's outcomes, provides a robust foundation for national consensus guideline development. This work's principal contribution is demonstrating that dysphoria-informed care can move from theoretical framework to functioning clinical reality: a reproducible, multidisciplinary pathway showing that structural redesign of administrative, clinical, and psychosocial components improves access, engagement, and treatment completion for TGD individuals.
引用
- Tsonis O, Shanbhag N, Grace J, et al. Trans-inclusive fertility preservation in the UK: evidence-based clinical guidance, the TransFertility service model and the case for a national pathway. Reprod Biomed Online. 2026. PMID: 42561480. doi:10.1016/j.rbmo.2026.105839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。